According to Zhitong Finance App News, GUANZE MEDICAL (02427) issued an announcement. On April 1, 2024, in accordance with the recommendations of the company's remuneration committee, the board of directors decided to award a total of 7.586 million bonus shares to 35 selected participants (all group employees) in accordance with the share award plan. Award shares are awarded at zero cost in accordance with the program rules and accepted by selected participants in accordance with the grant terms.
The 7.586 million bonus shares granted to selected participants represented approximately 0.80% of the company's issued share capital as of the date of this announcement. According to the plan rules, award shares can only be paid for shares purchased from the open market by the trustee or trust holding company, so the grant will not cause any dilution of the company's existing shareholders' shares.
Following the award, 2 of the 35 selected participants have resigned. Accordingly, according to the rules of the plan, the 472,000 award shares granted to these two employees expired on the date of this announcement.
The company shall induce the trustee or trust holding company to purchase the company's existing shares on the market to satisfy the grant after ownership. Funds for the purchase of existing shares by a trustee or trust holding company are provided by the company in accordance with the rules of the plan.
The company's trustee notified that from April 2, 2024 to April 30, 2024, the trustee or trust holding company had purchased a total of 2,536 million shares on the market at a total cost of HK$2,086,400.